Facial Fat Transfer: A Review

Overview · Recovery · Preparation · Complications · Techniques · Controversies · Evidence · Related articles · question library below

Facial fat transfer (fat grafting, lipofilling) harvests a small amount of the patient's own fat, refines it, and injects it in fine threads to restore facial volume: temples, cheeks, under eye hollows, lips, jawline, and the marionette region. It answers aging's subtraction with living tissue rather than a synthetic gel, and its central bargain is biological: what survives is durable for years; how much survives is only partly predictable. Our engine's review, facial fat graft survival (Grade B), lands where the literature does: commonly cited retention in the 30 to 70 percent range by site and technique, stabilizing over roughly three months, with surgeons planning modest overcorrection or staged sessions accordingly.

Fat versus filler, the honest comparison

Filler is precise, reversible, office based, and temporary; fat is surgical, permanent in what survives, natural in feel, and comes with donor site liposuction. Costs cross over after a few filler years. Neither wins globally: small precise corrections favor filler; broad multi area restoration favors fat; many faces use both in sequence. The interaction file with surgery lives in Injectables.

The operation

Alone, one to two hours under local with sedation: gentle low pressure liposuction (abdomen or thighs), processing (rinsing, decanting, or centrifugation), then micro droplet injection through blunt cannulas in multiple passes and planes. It is also the standard volume companion inside facelifts.

• Days 1 to 7: the overfilled phase: swelling plus planned overcorrection reads as too much, by design; bruising at face and donor sites; cold compresses and elevation.
• Weeks 2 to 3: socially presentable for most; donor soreness like a workout.
• Months 1 to 3: the resorption settling: volume recedes toward the durable result as non surviving graft clears; judging or topping up earlier misreads biology.
• Month 3 onward: what remains is yours: it ages, and gains and loses subtly with body weight, the property that makes large weight swings the enemy of a stable result.

Standard file applies (nicotine above all: graft survival is blood supply, medication windows, GLP-1 disclosure). Specific homework: weight stability honestly assessed (grafts mirror weight); prior filler mapped and discussed (residual gel occupies planes and confuses assessment); and expectations set for possible second sessions, which are technique standard, not failure.

Questions that separate surgeons

Volume philosophy per area; retention expectations they quote and how they handle shortfall; their approach to the periocular danger zones; and healed photographs at a year, when survival, not swelling, is on display.

• Common and manageable: prolonged swelling, bruising, asymmetric take, under correction (resorption variance), palpable small lumps, donor site irregularity.
• Uncommon: oil cysts and fat necrosis nodules; overcorrection, which in the periocular area is stubborn; infection.
• Rare and grave, stated plainly: intravascular injection causing skin loss or, in the worst reported cases, vision loss or stroke, the same vascular physics as filler, mitigated by blunt cannulas, low pressure, moving injection, and anatomical training. It is rare; it is why injector selection is a safety decision, not a luxury: Patient Safety.

Sudden severe pain, skin whitening, or visual symptoms during or after injection are emergencies: emergency guidance.

Processing debates (centrifuge versus rinse versus decant) fill journals without a crowned winner; survival tracks gentle handling and injection discipline more than any branded system, the recurring pattern this site keeps finding.

Survival number marketing

Quoted retention ranges from pessimistic to miraculous depending on who profits; the honest band (roughly 30 to 70 percent, site and technique dependent, per the cited answer) is wide because biology is. Distrust precision.

Regenerative add ons

Stem cell branding sells; controlled comparative evidence for enrichment remains mixed, and regulators have repeatedly policed the gap between the label and the proof. Real science exists here; so does premium priced hope.

The overfilled face era

Fat contributed to the overdone midfaces of the last decade just as filler did. The correction is aesthetic judgment and restraint, not the tool; portfolios reveal which a surgeon practices.

• Grade B: survival ranges and their stabilization timeline; the safety mechanics shared with injectables.
• Grade C: processing and variant comparisons; enrichment add ons, where evidence is inconsistent.
• Queue: standardized retention measurement and long term periocular outcomes.

Injectables · Facelift: A Review · Buccal Fat Removal: A Review · Liposuction: A Review · Patient Safety.

The complete question library for this topic follows below.